IVERS-READ GILLIAN C (See Remarks) sold 1.2% of their position (3.68K shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $3.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/3/2022ACC: 0000899243-22-034897
Officer· See Remarks
Since Sep 2018
-3.68K
Net shares
Net seller
$3.6K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
8.37K acquired · 12.05K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
1.3%
11/1/2022
288.92K→292.67K
Common Stock
Direct
Shares
+4.63K
Price / share
—
Trade value
—
% of position
1.6%
11/1/2022
290.99K→295.62K
Common Stock
Direct
Shares
−1.68K
Price / share
$0.98
Trade value
$1.65K
% of position
0.6%
11/2/2022
292.67K→290.99K
Common Stock
Direct
Shares
−2.01K
Price / share
$0.98
Trade value
$1.97K
% of position
0.7%
11/2/2022
295.62K→293.61K
Total
Net shares
+4.69K
Net value
-$3.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2022 | M · Option Exercise | +3.75K | — | — | 1.3% | 288.92K | 292.67K |
| Common Stock Direct | 11/1/2022 | M · Option Exercise | +4.63K | — | — | 1.6% | 290.99K | 295.62K |
| Common Stock Direct | 11/2/2022 | S · Sale | −1.68K | $0.98 | $1.65K | 0.6% | 292.67K | 290.99K |
| Common Stock Direct | 11/2/2022 | S · Sale | −2.01K | $0.98 | $1.97K | 0.7% | 295.62K | 293.61K |
| Total | +4.69K | -$3.62K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
3.75K
Exercisable
—
11/1/2022
Restricted Stock Units
Direct
Converts to
Common Stock
4.63K shares
Shares
−4.63K
Strike price
Held after
23.13K
Exercisable
—
11/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 11/1/2022 | M · Option Exercise | −3.75K | — | 3.75K | |
| Restricted Stock Units Direct | Common Stock4.63K shares | 11/1/2022 | M · Option Exercise | −4.63K | — | 23.13K |